Abstract:BACKGROUND:The roles of TMEM206, a new transmembrane protein, in cancer, including colorectal cancer (CRC), are unknown. Related family members, including TMEM16A, TMEM132A, and TMEM176B, have been shown to be involved in various biological behaviors. In addition, TMEM88 has been reported to promote non-small-cell lung cancer. In this study, we examined the roles of TMEM206 in CRC.METHOD:Real-time reverse transcription polymerase chain reaction was used to measure TMEM206 messenger RNA (mRNA) levels in clinical specimens and transfected cell lines. Immunohistochemistry was used to determine the relationship between TMEM206 expression levels and clinical data. Plasmids and small interfering RNA were used to upregulate and silence TMEM206, respectively. Protein expression levels and signaling pathway modulation were validated through western blot analysis. Colony formation, MTT, cell migration and invasion assays, and flow cytometry analyses were used to test the potential roles of TMEM206 in CRC. Co-immunoprecipitation was used to evaluate the interaction between TMEM206 and AKT.RESULTS:Investigation of the clinical significance of TMEM206 expression in CRC tissues revealed that TMEM206 mRNA and protein levels were higher in CRC tissues than in paired normal adjacent tissues (p < 0.05). TMEM206 overexpression was positively associated with T stage of cancer and UICC stage ( p < 0.05) and negatively related to differentiation of CRC ( p = 0.015). Upregulation or silencing of TMEM206 promoted or inhibited the proliferation of CRC cells and positively or negatively regulated the levels of phospho-AKT and downstream signaling pathway components (phospho-glycogen synthase kinase 3β and cyclin D1), respectively. Moreover, silencing of TMEM206 in cell lines arrested CRC cells in the G1 stage of the cell-cycle. In addition, upregulating or silencing TMEM206 increased or decreased cell invasion and migration in vitro and positively or negatively altered levels of the phospho-extracellular signal-regulated kinase (ERK) and phospho-focal adhesion kinase 397, respectively. Co-immunoprecipitation demonstrated that AKT and TMEM206 proteins interacted. Furthermore, TMEM206 promoted the development and progression of CRC by enhancing the interactions between the AKT and ERK signaling pathways.CONCLUSION:TMEM206 controlled the progression of CRC by accelerating CRC cell proliferation and promoting CRC cell migration and invasion. The target of TMEM206 may be AKT, which is known to be involved in modulating the biological behaviors of various cancers.

Transmembrane Protein 100 Inhibits the Progression of Colorectal Cancer by Promoting the Ubiquitin/Proteasome Degradation of HIF-1α

Novel roles of TMEM100: inhibition metastasis and proliferation of hepatocellular carcinoma.

Low-Expression of Tmem100 is Associated with Poor Prognosis in Non-Small-Cell Lung Cancer

TMEM166 inhibits cell proliferation, migration and invasion in hepatocellular carcinoma via upregulating TP53

Retracted: TMEM206 Promotes the Malignancy of Colorectal Cancer Cells by Interacting with AKT and Extracellular Signal‐regulated Kinase Signaling Pathways

Inhibition of TMEM16A expression suppresses growth and invasion in human colorectal cancer cells.

TMEM106C Contributes to the Malignant Characteristics and Poor Prognosis of Hepatocellular Carcinoma.

TMEM100 Negatively Regulated by Microrna‑106b Facilitates Cellular Apoptosis by Suppressing Survivin Expression in NSCLC.

TMEM206 is a Potential Prognostic Marker of Hepatocellular Carcinoma

TMEM100 Mediates Inflammatory Cytokines Secretion in Hepatic Stellate Cells and Its Mechanism Research.

TMEM211 Promotes Tumor Progression and Metastasis in Colon Cancer

Integrative Multi-Omics Analysis Identifies Transmembrane p24 Trafficking Protein 1 (TMED1) as a Potential Prognostic Marker in Colorectal Cancer

Downregulation of TMEM220 Promotes Tumor Progression in Hepatocellular Carcinoma

Regulation of TMEM100 Expression by Epigenetic Modification, Effects on Proliferation and Invasion of Esophageal Squamous Carcinoma

Expression Of Tmem16a In Colorectal Cancer And Its Correlation With Clinical And Pathological Parameters

TGFβ1I1 Suppressed Cell Migration and Invasion in Colorectal Cancer by Inhibiting the TGF-β Pathway and EMT Progress.

Inner nuclear membrane protein TMEM201 promotes breast cancer metastasis by positive regulating TGFβ signaling

TMUB1 as a diagnostic and prognostic marker for colorectal cancer

CTHRC1 Overexpression Predicts Poor Survival and Enhances Epithelial‐mesenchymal Transition in Colorectal Cancer

TMEM97 knockdown inhibits 5‐fluorouracil resistance by regulating epithelial‐mesenchymal transition and ABC transporter expression via inactivating the Akt/mTOR pathway in 5‐fluorouracil‐resistant colorectal cancer cells

TMEM60 Promotes the Proliferation and Migration and Inhibits the Apoptosis of Glioma Through Modulating AKT Signaling